Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Bladder Cancer

Free Subscription Articles published in J Urol Retrieve available abstracts of 193 articles: HTML format

Single Articles

June 2008
1. HUANG GJ , Hamilton AS, Lo M, Stein JP, et al
   Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care Project.
   J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. LOTAN Y , Bensalah K, Ruddell T, Shariat SF, et al
   Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
   J Urol. 2008;179:2164-9.
   PubMed     Related articles    Abstract available
   
   
   
3. ROZET F , Lesur G, Cathelineau X, Barret E, et al
   Oncological evaluation of prostate sparing cystectomy: the Montsouris long-term results.
   J Urol. 2008;179:2170-4.
   PubMed     Related articles    Abstract available
   
   
   
4. RAFTERY D , Gowda GA
   An approaching new wave of multicomponent biomarker diagnostics?
   J Urol. 2008;179:2089-90.
   PubMed     Related articles   
   
   
   May 2008
5. SHI TP , Xu H, Wei JF, Ai X, et al
   Association of Low Expression of Notch-1 and Jagged-1 in Human Papillary Bladder Cancer and Shorter Survival.
   J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. HENDRICKSEN K , Gleason D, Young JM, Saltzstein D, et al
   Safety and Side Effects of Immediate Instillation of Apaziquone Following Transurethral Resection in Patients With Nonmuscle Invasive Bladder Cancer.
   J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. STROPE SA , Montie JE
   The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation.
   J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. CAI T , Nesi G, Tinacci G, Zini E, et al
   Early Single Dose Instillation of EpirubicinImprove Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.
   J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. CHROUSER K , Leibovich B, Bergstralh E, Zincke H, et al
   Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
   J Urol. 2008;179.
   PubMed     Related articles    Abstract available
   
   
   
10. NIEDER AM
    Commentary on association of clinical prostate and bladder cancers.
    J Urol. 2008;179.
    PubMed     Related articles   
    
    
    
11. SINGH A , Kinoshita Y, Rovito PM Jr, Landas S, et al
    Higher than expected association of clinical prostate and bladder cancers.
    J Urol. 2008;179.
    PubMed     Related articles    Abstract available
    
    
    
12. KONETY BR
    Commentary on the etiologic relationship between prostate radiation and bladder cancer: the scourge for one is poison for the other.
    J Urol. 2008;179.
    PubMed     Related articles   
    
    
    
13. SAGALOWSKY AI
    Commentary on clinical outcomes of sexuality preserving cystectomy and neobladder.
    J Urol. 2008;179.
    PubMed     Related articles   
    
    
    
14. LOTAN Y
    Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
    J Urol. 2008;179.
    PubMed     Related articles   
    
    
    
15. HUYGENS A , Crnolatac I, Develter J, Van Cleynenbreugel B, et al
    Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin.
    J Urol. 2008;179:2014-9.
    PubMed     Related articles    Abstract available
    
    
    April 2008
16. SUZUKI K
    Re: Serum Tumor Markers May Predict Overall and Disease Specific Survival in Patients With Clinically Organ Confined Invasive Bladder Cancer D. Margel, R. Tal and J. Baniel J Urol 2007; 178: 2297-2301.
    J Urol. 2008;179:2481.
    PubMed     Related articles   
    
    
    
17. ISSAQ HJ , Nativ O, Waybright T, Luke B, et al
    Detection of Bladder Cancer in Human Urine by Metabolomic Profiling Using High Performance Liquid Chromatography/Mass Spectrometry.
    J Urol. 2008;179:2422-2426.
    PubMed     Related articles    Abstract available
    
    
    
18. LAMM DL
    Re: A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. S. J. Harland, H. Kynaston, K. Grigor, D. M. Wallace, C. Beacock, R. Kockelbergh, S. Clawson, T. Barlow, M. K. Parmar and G. O. Gr
    J Urol. 2008;179:1639-40.
    PubMed     Related articles   
    
    
    
19. MSEZANE L , Reynolds WS, Mhapsekar R, Gerber G, et al
    Open surgical repair of ureteral strictures and fistulas following radical cystectomy and urinary diversion.
    J Urol. 2008;179:1428-31.
    PubMed     Related articles    Abstract available
    
    
    March 2008
20. PUPPO P , Introini C, Bertolotto F, Naselli A, et al
    Potency Preserving Cystectomy With Intrafascial Prostatectomy for High Risk Superficial Bladder Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. DHAR NB , Klein EA, Reuther AM, Thalmann GN, et al
    Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    J Urol. 2008;179:873-8.
    PubMed     Related articles    Abstract available
    
    
    
22. VEMULAKONDA VM , Lendvay TS, Shnorhavorian M, Joyner BD, et al
    Metastatic adenocarcinoma after augmentation gastrocystoplasty.
    J Urol. 2008;179:1094-6.
    PubMed     Related articles    Abstract available
    
    
    February 2008
23. SCHULTZEL M , Saltzstein SL, Downs TM, Shimasaki S, et al
    Late Age (85 Years or Older) Peak Incidence of Bladder Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. KIPP BR , Halling KC, Campion MB, Wendel AJ, et al
    Assessing the Value of Reflex Fluorescence In Situ Hybridization Testing in the Diagnosis of Bladder Cancer When Routine Urine Cytological Examination is Equivocal.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. PAN CW , Shen ZJ, Ding GQ
    The Effect of Intravesical Instillation of Antifibrinolytic Agents on Bacillus Calmette-Guerin Treatment of Superficial Bladder Cancer: A Pilot Study.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. SVATEK RS , Karam J, Karakiewicz PI, Gallina A, et al
    Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
    J Urol. 2008;179:478-84.
    PubMed     Related articles    Abstract available
    
    
    January 2008
27. BERRUM-SVENNUNG I , Granfors T, Jahnson S, Boman H, et al
    A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
    J Urol. 2008;179:101-5.
    PubMed     Related articles    Abstract available
    
    
    
28. TRAN W , Serio AM, Raj GV, Dalbagni G, et al
    Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
    J Urol. 2008;179:96-100.
    PubMed     Related articles    Abstract available
    
    
    
29. PRUTHI RS , Baldwin N, Bhalani V, Wallen EM, et al
    Conservative management of low risk superficial bladder tumors.
    J Urol. 2008;179:87-90.
    PubMed     Related articles    Abstract available
    
    
    
30. HERR HW
    Low risk bladder tumors--less is more!
    J Urol. 2008;179:13-4.
    PubMed     Related articles   
    
    
    
31. BOUCHELOUCHE K , Oehr P
    Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    J Urol. 2008;179:34-45.
    PubMed     Related articles    Abstract available
    
    
    December 2007
32. LAMM DL
    Re: Patterns of Recurrence and Outcomes Following Induction Bacillus Calmette-Guerin for High Risk Ta, T1 Bladder Cancer S. P. Lerner, C. M. Tangen, H. Sucharew, D. Wood and E. D. CrawfordJ Urol 2007; 177: 1727-1731.
    J Urol. 2007;.
    PubMed     Related articles   
    
    
    
33. HOQUE MO , Begum S, Brait M, Jeronimo C, et al
    Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. NAITO S , Koga H, Yamaguchi A, Fujimoto N, et al
    Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. NIEDER AM , Mackinnon JA, Huang Y, Fleming LE, et al
    Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. HALL MC , Chang SS, Dalbagni G, Pruthi RS, et al
    Guideline for the management of nonmuscle invasive bladder cancer (stages ta, t1, and tis): 2007 update.
    J Urol. 2007;178:2314-30.
    PubMed     Related articles   
    
    
    
37. YUTKIN V , Pode D, Pikarsky E, Mandelboim O, et al
    The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    J Urol. 2007;178:2660-4.
    PubMed     Related articles    Abstract available
    
    
    
38. MEISSNER C , Giannarini G, Schumacher MC, Thoeny H, et al
    The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer.
    J Urol. 2007;178:2287-90.
    PubMed     Related articles    Abstract available
    
    
    
39. GRIFFITH TS
    Predicting bacillus Calmette-Guerin immunotherapy effectiveness.
    J Urol. 2007;178:2247-8.
    PubMed     Related articles   
    
    
    
40. SAITO K , Kawakami S, Fujii Y, Sakura M, et al
    Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    J Urol. 2007;178:2291-6.
    PubMed     Related articles    Abstract available
    
    
    
41. PANTUCK AJ , Baniel J, Kirkali Z, Klatte T, et al
    A novel resectoscope for transurethral resection of bladder tumors and the prostate.
    J Urol. 2007;178:2331-6.
    PubMed     Related articles    Abstract available
    
    
    
42. KOCH MO
    Positive margins in urological oncology.
    J Urol. 2007;178:2249.
    PubMed     Related articles   
    
    
    
43. WRIGHT JL , Black PC, Brown GA, Porter MP, et al
    Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    J Urol. 2007;178:2302-6.
    PubMed     Related articles    Abstract available
    
    
    November 2007
44. ELLINGER J , El Kassem N, Heukamp LC, Matthews S, et al
    Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. KASSOUF W , Black PC, Tuziak T, Bondaruk J, et al
    Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. BOSTROM PJ , Soloway MS, Manoharan M, Ayyathurai R, et al
    Bladder Cancer After Radiotherapy for Prostate Cancer: Detailed Analysis of Pathological Features and Outcome After Radical Cystectomy.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. HERR HW , Morales A
    History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. CHEN F , Zhang G, Cao Y, Payne R, et al
    Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
    J Urol. 2007;178:2166-70.
    PubMed     Related articles    Abstract available
    
    
    
49. SPEERS AG , Lwaleed BA, Featherstone JM, Cooper AJ, et al
    Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C.
    J Urol. 2007;178:2171-5.
    PubMed     Related articles    Abstract available
    
    
    
50. DIPAOLA RS , Lattime EC
    Bacillus Calmette-Guerin mechanism of action: the role of immunity, apoptosis, necrosis and autophagy.
    J Urol. 2007;178:1840-1.
    PubMed     Related articles   
    
    
    
51. CAI T , Mazzoli S, Meacci F, Tinacci G, et al
    Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
    J Urol. 2007;178:1906-11.
    PubMed     Related articles    Abstract available
    
    
    October 2007
52. MARGEL D , Tal R, Baniel J
    Serum Tumor Markers May Predict Overall and Disease Specific Survival in Patients With Clinically Organ Confined Invasive Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. HEMAL AK , Kolla SB
    Comparison of Laparoscopic and Open Radical Cystoprostatectomy for Localized Bladder Cancer With 3-Year Oncological Followup: A Single Surgeon Experience.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. SOLER-MARTINEZ J , Vozmediano-Chicharro R, Morales-Jimenez P, Hernandez-Alcaraz D, et al
    Holmium Laser Treatment for Low Grade, Low Stage, Noninvasive Bladder Cancer With Local Anesthesia and Early Instillation of Mitomycin C.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. DOTAN ZA , Kavanagh K, Yossepowitch O, Kaag M, et al
    Positive Surgical Margins in Soft Tissue Following Radical Cystectomy for Bladder Cancer and Cancer Specific Survival.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. JACOBS MA , Wotkowicz C, Baumgart ED, Neto BS, et al
    Epidermal growth factor receptor status and the response of bladder carcinoma cells to erlotinib.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
57. BARBIERI CE , Lee B, Cookson MS, Bingham J, et al
    Association of procedure volume with radical cystectomy outcomes in a nationwide database.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
58. STEVEN K , Poulsen AL
    Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
59. ABBOD MF , Catto JW, Linkens DA, Hamdy FC, et al
    Application of artificial intelligence to the management of urological cancer.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
60. HERR HW , Donat SM, Reuter VE
    Management of low grade papillary bladder tumors.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
61. CASTELLAN M , Gosalbez R, Perez-Brayfield M, Healey P, et al
    Tumor in bladder reservoir after gastrocystoplasty.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    September 2007
62. KRAMBECK AE , Thompson RH, Lohse CM, Patterson DE, et al
    Imperative indications for conservative management of upper tract transitional cell carcinoma.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
63. PRUTHI RS , Wallen EM
    Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    
64. HARLAND SJ , Kynaston H, Grigor K, Wallace DM, et al
    A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder.
    J Urol. 2007;178.
    PubMed     Related articles    Abstract available
    
    
    August 2007
65. GUPTA NP , Kolla SB, Seth A, Hemal AK, et al
    Oncological and Functional Outcome of Radical Cystectomy in Patients With Bladder Cancer and Obstructive Uropathy.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. LAMM D
    Bladder Cancer: Improving Care With Better Classification and Risk Stratification.
    J Urol. 2007;.
    PubMed     Related articles   
    
    
    
67. SCHNED AR , Andrew AS, Marsit CJ, Zens MS, et al
    Survival Following the Diagnosis of Noninvasive Bladder Cancer: WHO/International Society of Urological Pathology Versus WHO Classification Systems.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. ZAGHLOUL MS
    Re: patterns of initial transitional cell recurrence in patients after cystectomy.
    J Urol. 2007;178:730.
    PubMed     Related articles   
    
    
    
69. EHRLICH Y , Yossepowitch O, Margel D, Lask D, et al
    Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
    J Urol. 2007;178:524-8.
    PubMed     Related articles    Abstract available
    
    
    July 2007
70. EISSA S , Swellam M, Ali-Labib R, Mansour A, et al
    Detection of Telomerase in Urine by 3 Methods: Evaluation of Diagnostic Accuracy for Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. ITO M , Nishiyama H, Kawanishi H, Matsui S, et al
    P21-Activated Kinase 1: A New Molecular Marker for Intravesical Recurrence After Transurethral Resection of Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. DIVRIK RT , Sahin A, Altok M, Unlu N, et al
    The Frequency of Hydronephrosis at Initial Diagnosis and its Effect on Recurrence and Progression in Patients With Superficial Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. KOUBA E , Sands M, Lentz A, Wallen E, et al
    A Comparison of the Bricker Versus Wallace Ureteroileal Anastomosis in Patients Undergoing Urinary Diversion for Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. KOUBA E , Sands M, Lentz A, Wallen E, et al
    Incidence and Risk Factors of Stomal Complications in Patients Undergoing Cystectomy With Ileal Conduit Urinary Diversion for Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. AUSTIN JC , Elliott S, Cooper CS
    Patients With Spina Bifida and Bladder Cancer: Atypical Presentation, Advanced Stage and Poor Survival.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. STEIN JP , Penson DF, Wu SD, Skinner DG, et al
    Pathological Guidelines for Orthotopic Urinary Diversion in Women With Bladder Cancer: A Review of the Literature.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. BRAVACCINI S , Sanchini MA, Granato AM, Gunelli R, et al
    Urine telomerase activity for the detection of bladder cancer in females.
    J Urol. 2007;178:57-61.
    PubMed     Related articles    Abstract available
    
    
    
78. BOSTROM PJ , Soloway MS
    Upper urinary tract cancer--challenges for the urologist.
    J Urol. 2007;178:12-3.
    PubMed     Related articles   
    
    
    
79. KAWAKAMI K , Enokida H, Tachiwada T, Nishiyama K, et al
    Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma.
    J Urol. 2007;178:301-7.
    PubMed     Related articles    Abstract available
    
    
    
80. HERR HW , Bochner BH, Sharp D, Dalbagni G, et al
    Urachal carcinoma: contemporary surgical outcomes.
    J Urol. 2007;178:74-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
81. ORD JJ , Agrawal S, Thamboo TP, Roberts I, et al
    An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. TAL R , Sivan B, Kedar D, Baniel J, et al
    Management of Benign Ureteral Strictures Following Radical Cystectomy and Urinary Diversion for Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. DAVID KA , Milowsky MI, Ritchey J, Carroll PR, et al
    Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. SMITH EB , Schwartz M, Kawamoto H, You X, et al
    Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
    J Urol. 2007;177:2347-51.
    PubMed     Related articles    Abstract available
    
    
    
85. HOLLENBECK BK , Daignault S, Dunn RL, Gilbert S, et al
    Getting under the hood of the volume-outcome relationship for radical cystectomy.
    J Urol. 2007;177:2095-9.
    PubMed     Related articles    Abstract available
    
    
    
86. SANDERSON KM , Cai J, Miranda G, Skinner DG, et al
    Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    J Urol. 2007;177:2088-94.
    PubMed     Related articles    Abstract available
    
    
    May 2007
87. NIEDER AM , Soloway MS, Jewett MA
    Re: Can Restaging Transurethral Resection of T1 Bladder Cancer Select Patients for Immediate Cystectomy? H. W. Herr, S. M. Donat and G. DalbagniJ Urol 2007; 177: 75-79.
    J Urol. 2007;.
    PubMed     Related articles   
    
    
    
88. FRADET Y , Grossman HB, Gomella L, Lerner S, et al
    A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. GROSSMAN HB , Gomella L, Fradet Y, Morales A, et al
    A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer.
    J Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
90. ADAM L , Black PC, Kassouf W, Eve B, et al
    Adenoviral Mediated Interferon-alpha 2b Gene Therapy Suppresses the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Superficial Bladder Cancer.
    J Urol. 2007;177:1900-6.
    PubMed     Related articles    Abstract available
    
    
    
91. LERNER SP , Tangen CM, Sucharew H, Wood D, et al
    Patterns of recurrence and outcomes following induction bacillus calmette-guerin for high risk ta, t1 bladder cancer.
    J Urol. 2007;177:1727-31.
    PubMed     Related articles    Abstract available
    
    
    
92. GOLDMAN HB , McAchran SE, MacLennan GT
    Leiomyoma of the urethra and bladder.
    J Urol. 2007;177:1890.
    PubMed     Related articles   
    
    
    
93. KRAMBECK AE , Thompson RH, Lohse CM, Patterson DE, et al
    Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    J Urol. 2007;177:1721-6.
    PubMed     Related articles    Abstract available
    
    
    
94. CATTO JW , Yates DR, Rehman I, Azzouzi AR, et al
    Behavior of urothelial carcinoma with respect to anatomical location.
    J Urol. 2007;177:1715-20.
    PubMed     Related articles    Abstract available
    
    
    
95. KONETY BR , Joyce GF, Wise M
    Bladder and upper tract urothelial cancer.
    J Urol. 2007;177:1636-45.
    PubMed     Related articles    Abstract available
    
    
    April 2007
96. LEWIN JM , Lwaleed BA, Cooper AJ, Birch BR, et al
    The direct effect of nuclear pores on nuclear chemotherapeutic concentration in multidrug resistant bladder cancer: the nuclear sparing phenomenon.
    J Urol. 2007;177:1526-30.
    PubMed     Related articles    Abstract available
    
    
    
97. WEIZER AZ , Joshi D, Daignault S, Kinnaman M, et al
    Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer.
    J Urol. 2007;177:1287-93.
    PubMed     Related articles    Abstract available
    
    
    
98. RAJ GV , Herr H, Serio AM, Donat SM, et al
    Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.
    J Urol. 2007;177:1283-6.
    PubMed     Related articles    Abstract available
    
    
    
99. YOSSEPOWITCH O , Herr HW, Donat SM
    Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
    J Urol. 2007;177:1277-82.
    PubMed     Related articles    Abstract available
    
    
    
100. HERR HW
     The concept of lymph node density--is it ready for clinical practice?
     J Urol. 2007;177:1273-5.
     PubMed     Related articles    Abstract available
     
     
     March 2007
101. SATOH H , Morimoto Y, Arai T, Asanuma H, et al
     Intravesical Ultrasonography for Tumor Staging in an Orthotopically Implanted Rat Model of Bladder Cancer.
     J Urol. 2007;177:1169-1173.
     PubMed     Related articles    Abstract available
     
     
     
102. BOORJIAN S , Cowan JE, Konety BR, Duchane J, et al
     Bladder cancer incidence and risk factors in men with prostate cancer: results from cancer of the prostate strategic urologic research endeavor.
     J Urol. 2007;177:883-8.
     PubMed     Related articles    Abstract available
     
     
     
103. STEIN JP , Penson DF, Cai J, Miranda G, et al
     Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
     J Urol. 2007;177:876-82.
     PubMed     Related articles    Abstract available
     
     
     
104. CHOI YD , Cho NH, Ahn HS, Cho KS, et al
     Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
     J Urol. 2007;177:1174-8.
     PubMed     Related articles    Abstract available
     
     
     
105. MARGULIS V , Shariat SF, Ashfaq R, Thompson M, et al
     Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
     J Urol. 2007;177:1163-8.
     PubMed     Related articles    Abstract available
     
     
     
106. MARIAPPAN P , Smith G, Lamb AD, Grigor KM, et al
     Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades.
     J Urol. 2007;177:867-75.
     PubMed     Related articles    Abstract available
     
     
     
107. ADAM R
     Cyclooxygenase-2 in transitional cell carcinoma--a legitimate target?
     J Urol. 2007;177:818-9.
     PubMed     Related articles   
     
     
     February 2007
108. YU DS , Lee CF, Chang SY
     Immunotherapy for orthotopic murine bladder cancer using bacillus calmette-guerin recombinant protein mpt-64.
     J Urol. 2007;177:738-42.
     PubMed     Related articles    Abstract available
     
     
     
109. HERR HW , Dotan Z, Donat SM, Bajorin DF, et al
     Defining optimal therapy for muscle invasive bladder cancer.
     J Urol. 2007;177:437-43.
     PubMed     Related articles    Abstract available
     
     
     
110. JARGIN SV
     Re: Involvement of ubiquitination and sumoylation in bladder lesions induced by persistent long-term low dose ionizing radiation in humans and Re: DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine.
     J Urol. 2007;177:794.
     PubMed     Related articles   
     
     
     
111. SHARIAT SF , Ashfaq R, Sagalowsky AI, Lotan Y, et al
     Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
     J Urol. 2007;177:481-7.
     PubMed     Related articles    Abstract available
     
     
     January 2007
112. MOONEN PM , van Balken-Ory B, Kiemeney LA, Schalken JA, et al
     Prognostic value of p53 for high risk superficial bladder cancer with long-term followup.
     J Urol. 2007;177:80-3.
     PubMed     Related articles    Abstract available
     
     
     
113. HERR HW , Donat SM, Dalbagni G
     Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
     J Urol. 2007;177:75-9.
     PubMed     Related articles    Abstract available
     
     
     
114. BRANDAU S
     Local and systemic immune suppression in bladder cancer.
     J Urol. 2007;177:12-3.
     PubMed     Related articles   
     
     
     
115. LOSKOG A , Ninalga C, Paul-Wetterberg G, de la Torre M, et al
     Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines.
     J Urol. 2007;177:353-8.
     PubMed     Related articles    Abstract available
     
     
     
116. KONETY BR , Allareddy V
     Influence of post-cystectomy complications on cost and subsequent outcome.
     J Urol. 2007;177:280-7.
     PubMed     Related articles    Abstract available
     
     
     
117. LIN CC , Hsu CH, Huang CY, Cheng AL, et al
     Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
     J Urol. 2007;177:84-9.
     PubMed     Related articles    Abstract available
     
     
     December 2006
118. HORAN AH
     Re: cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival C. T. Lee, R. Madii, s. Daignault, R. L. Dunn, y. Zhang, j. E. Montie and d. P. Wood, jr., j urol, 175: 1262-1267,
     J Urol. 2006;176:2744.
     PubMed     Related articles   
     
     
     
119. MOLTEDO B , Faunes F, Haussmann D, De Ioannes P, et al
     Immunotherapeutic effect of concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins.
     J Urol. 2006;176:2690-5.
     PubMed     Related articles    Abstract available
     
     
     
120. TAUB DA , Dunn RL, Miller DC, Wei JT, et al
     Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care.
     J Urol. 2006;176:2612-8.
     PubMed     Related articles    Abstract available
     
     
     
121. GUTIERREZ J , Jimenez A, de Dios Luna J, Soto MJ, et al
     Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus.
     J Urol. 2006;176:2474-81.
     PubMed     Related articles    Abstract available
     
     
     
122. SHARIAT SF , Karakiewicz PI, Palapattu GS, Lotan Y, et al
     Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium.
     J Urol. 2006;176:2414-22.
     PubMed     Related articles    Abstract available
     
     
     
123. NIEDER AM , John S, Messina CR, Granek IA, et al
     Are patients aware of the association between smoking and bladder cancer?
     J Urol. 2006;176:2405-8.
     PubMed     Related articles    Abstract available
     
     
     
124. LOKESHWAR VB
     Are there molecular signatures for predicting bladder cancer prognosis?
     J Urol. 2006;176:2347-8.
     PubMed     Related articles   
     
     
     
125. LAMY A , Gobet F, Laurent M, Blanchard F, et al
     Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
126. SAMUEL JD , Bhatt RI, Montague RJ, Clarke NW, et al
     The natural history of postoperative renal function in patients undergoing ileal conduit diversion for cancer measured using serial isotopic glomerular filtration rate and 99m technetium-mercaptoacetyltriglycine renography.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
127. SCHUMACHER MC , Scholz M, Weise ES, Fleischmann A, et al
     Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder?
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
128. MURPHY WM
     What's the trouble with cytology?
     J Urol. 2006;176.
     PubMed     Related articles   
     
     
     November 2006
129. BUSBY JE , Kamat AM
     Chemoprevention for bladder cancer.
     J Urol. 2006;176:1914-20.
     PubMed     Related articles    Abstract available
     
     
     
130. REID PITTS W JR
     Re: bladder tumor markers.
     J Urol. 2006;176:2308.
     PubMed     Related articles   
     
     
     
131. HSU PY , Liu HS, Cheng HL, Tzai TS, et al
     Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.
     J Urol. 2006;176:2262-7.
     PubMed     Related articles    Abstract available
     
     
     
132. RANEY B , Anderson J, Jenney M, Arndt C, et al
     Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop.
     J Urol. 2006;176:2190-4.
     PubMed     Related articles    Abstract available
     
     
     
133. KORAITIM MM , Atta MA, Foda MK
     Orthotopic bladder substitution in men revisited: identification of continence predictors.
     J Urol. 2006;176:2081-4.
     PubMed     Related articles    Abstract available
     
     
     
134. RAJ GV , Bochner BH, Serio AM, Vickers A, et al
     Natural history of positive urinary cytology after radical cystectomy.
     J Urol. 2006;176:2000-5.
     PubMed     Related articles    Abstract available
     
     
     
135. THOMAS CY , Theodorescu D
     Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.
     J Urol. 2006;176:1909-10.
     PubMed     Related articles   
     
     
     October 2006
136. VAN DER HEIJDEN AG , Moonen PM, Cornel EB, Vergunst H, et al
     Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response.
     J Urol. 2006;176:1349-53.
     PubMed     Related articles    Abstract available
     
     
     
137. PURI R , Palit V, Loadman PM, Flannigan M, et al
     Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer.
     J Urol. 2006;176:1344-8.
     PubMed     Related articles    Abstract available
     
     
     
138. GODBOLE P , Outram A, Wilcox DT, Duffy PG, et al
     Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
139. KASSOUF W , Highshaw R, Nelkin GM, Dinney CP, et al
     Vitamins C and K3 sensitize human urothelial tumors to gemcitabine.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
140. HOLLENBECK BK , Miller DC, Taub DA, Dunn RL, et al
     The effects of adjusting for case mix on mortality and length of stay following radical cystectomy.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
141. KARAKIEWICZ PI , Shariat SF, Palapattu GS, Gilad AE, et al
     Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
142. FERRER FA , Isakoff M, Koyle MA
     Bladder/prostate rhabdomyosarcoma: past, present and future.
     J Urol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
143. WOMER RB , Snyder HM
     Bladder/prostate rhabdomyosarcoma: miles to go before we sleep.
     J Urol. 2006;176.
     PubMed     Related articles   
     
     
     September 2006
144. FURUKAWA J , Hara I, Nagai H, Yao A, et al
     Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response.
     J Urol. 2006;176:1198-203.
     PubMed     Related articles    Abstract available
     
     
     
145. HUNG RJ , Zhang ZF, Rao JY, Pantuck A, et al
     Protective effects of plasma carotenoids on the risk of bladder cancer.
     J Urol. 2006;176:1192-7.
     PubMed     Related articles    Abstract available
     
     
     
146. COLOMBEL M , Saint F, Chopin D, Malavaud B, et al
     The Effect of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients With Superficial Bladder Cancer: Results of a Randomized, Prospective, Double-Blind, Placebo Controlled, Multicenter Study.
     J Urol. 2006;176:935-939.
     PubMed     Related articles    Abstract available
     
     
     
147. LEE CT , Dunn RL, Williams C, Underwood W 3rd, et al
     Racial disparity in bladder cancer: trends in tumor presentation at diagnosis.
     J Urol. 2006;176:927-34.
     PubMed     Related articles    Abstract available
     
     
     
148. SHARIAT SF , Marberger MJ, Lotan Y, Sanchez-Carbayo M, et al
     Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
     J Urol. 2006;176:919-26.
     PubMed     Related articles    Abstract available
     
     
     
149. KONETY BR
     Bladder cancer prevention-could a carrot be the stick?
     J Urol. 2006;176:864-5.
     PubMed     Related articles   
     
     
     
150. JONES JS
     Re: Virtual cystoscopy by intravesical instillation of dilute contrast medium: preliminary experience. T. A. Kishore, G. K. George and S. Bhat. J Urol, 175: 870-874, 2006.
     J Urol. 2006;176:1251.
     PubMed     Related articles   
     
     
     
151. MAFFEZZINI M , Gerbi G, Campodonico F, Parodi D, et al
     A multimodal perioperative plan for radical cystectomy and urinary intestinal diversion: effects, limits and complications of early artificial nutrition.
     J Urol. 2006;176:945-8.
     PubMed     Related articles    Abstract available
     
     
     
152. GOFRIT ON , Mishani E, Orevi M, Klein M, et al
     Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
     J Urol. 2006;176:940-4.
     PubMed     Related articles    Abstract available
     
     
     August 2006
153. KASSOUF W , Luongo T, Brown G, Adam L, et al
     Schedule dependent efficacy of gefitinib and docetaxel for bladder cancer.
     J Urol. 2006;176:787-92.
     PubMed     Related articles    Abstract available
     
     
     
154. MESSING E , Kim KM, Sharkey F, Schultz M, et al
     Randomized Prospective Phase III Trial of Difluoromethylornithine vs Placebo in Preventing Recurrence of Completely Resected Low Risk Superficial Bladder Cancer.
     J Urol. 2006;176:500-4.
     PubMed     Related articles    Abstract available
     
     
     
155. YU RJ , Stein JP, Cai J, Miranda G, et al
     Superficial (pT2a) and Deep (pT2b) Muscle Invasion in Pathological Staging of Bladder Cancer Following Radical Cystectomy.
     J Urol. 2006;176:493-9.
     PubMed     Related articles    Abstract available
     
     
     
156. MONTIE JE
     Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.
     J Urol. 2006;176:507-8.
     PubMed     Related articles   
     
     
     
157. MONTIE JE
     Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
     J Urol. 2006;176:506-7.
     PubMed     Related articles   
     
     
     
158. NATURALE RT , Maclennan GT
     Small cell carcinoma of the bladder.
     J Urol. 2006;176:781.
     PubMed     Related articles   
     
     
     
159. HAUTMANN RE , Gschwend JE, de Petriconi RC, Kron M, et al
     Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.
     J Urol. 2006;176:486-92.
     PubMed     Related articles    Abstract available
     
     
     
160. YOSSEPOWITCH O , Eggener SE, Bochner BH, Donat SM, et al
     Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
     J Urol. 2006;176:482-5.
     PubMed     Related articles    Abstract available
     
     
     July 2006
161. PALOU J , Rodriguez O, Segarra J, Rosales A, et al
     Re: restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus calmette-guerin therapy h. W. Herr j urol, 174: 2134-2137, 2005.
     J Urol. 2006;176:407-8.
     PubMed     Related articles   
     
     
     
162. SAROSDY MF , Kahn PR, Ziffer MD, Love WR, et al
     Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria.
     J Urol. 2006;176:44-47.
     PubMed     Related articles    Abstract available
     
     
     
163. STUDER UE , Burkhard FC, Schumacher M, Kessler TM, et al
     Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned.
     J Urol. 2006;176:161-6.
     PubMed     Related articles    Abstract available
     
     
     
164. KASSOUF W , Leibovici D, Munsell MF, Dinney CP, et al
     Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
     J Urol. 2006;176:53-7.
     PubMed     Related articles    Abstract available
     
     
     
165. AKDOGAN B , Dogan HS, Eskicorapci SY, Sahin A, et al
     Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
     J Urol. 2006;176:48-52.
     PubMed     Related articles    Abstract available
     
     
     June 2006
166. MASOOD S , Pietrzak P, Kourief C, Vieira I, et al
     Re: treatment delay and prognosis in invasive bladder cancer f. Liedberg, h. Anderson and w. Mansson.
     J Urol. 2006;175:2364.
     PubMed     Related articles   
     
     
     
167. MOUSSA O , Abol-Enein H, Bissada NK, Keane T, et al
     Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
     J Urol. 2006;175:2312-6.
     PubMed     Related articles    Abstract available
     
     
     
168. FISHER HA
     Bladder cancer: in search of the right operation for the right patient.
     J Urol. 2006;175:1987-8.
     PubMed     Related articles   
     
     
     
169. SHAH SK , Lui PD, Baldwin DD, Ruckle HC, et al
     Urothelial carcinoma after external beam radiation therapy for prostate cancer.
     J Urol. 2006;175:2063-6.
     PubMed     Related articles    Abstract available
     
     
     
170. KASSOUF W , Swanson D, Kamat AM, Leibovici D, et al
     Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
     J Urol. 2006;175:2058-62.
     PubMed     Related articles    Abstract available
     
     
     
171. HASSAN JM , Cookson MS, Smith JA Jr, Chang SS, et al
     Patterns of initial transitional cell recurrence in patients after cystectomy.
     J Urol. 2006;175:2054-7.
     PubMed     Related articles    Abstract available
     
     
     
172. ROGERS CG , Palapattu GS, Shariat SF, Karakiewicz PI, et al
     Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
     J Urol. 2006;175:2048-53.
     PubMed     Related articles    Abstract available
     
     
     
173. BARTOLETTI R , Cai T, Dal Canto M, Boddi V, et al
     Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.
     J Urol. 2006;175:2032-7.
     PubMed     Related articles    Abstract available
     
     
     
174. KOYA MP , Simon MA, Soloway MS
     Complications of intravesical therapy for urothelial cancer of the bladder.
     J Urol. 2006;175:2004-10.
     PubMed     Related articles    Abstract available
     
     
     
175. JONES TD , Cheng L
     Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts.
     J Urol. 2006;175:1995-2003.
     PubMed     Related articles    Abstract available
     
     
     
176. GOMELLA LG
     Targeting the genetic basis of transitional cell carcinoma.
     J Urol. 2006;175:1986.
     PubMed     Related articles   
     
     
     May 2006
177. OHL F , Jung M, Radonic A, Sachs M, et al
     Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer.
     J Urol. 2006;175:1915-20.
     PubMed     Related articles    Abstract available
     
     
     
178. JOUDI FN , Smith BJ, O'donnell MA, Konety BR, et al
     The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy.
     J Urol. 2006;175:1634-40.
     PubMed     Related articles    Abstract available
     
     
     
179. INMAN BA
     Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.
     J Urol. 2006;175:1960.
     PubMed     Related articles   
     
     
     
180. PALAPATTU GS , Shariat SF, Karakiewicz PI, Bastian PJ, et al
     Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
     J Urol. 2006;175:1645-9.
     PubMed     Related articles    Abstract available
     
     
     
181. DIVRIK RT , Yildirim U, Zorlu F, Ozen H, et al
     The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
     J Urol. 2006;175:1641-4.
     PubMed     Related articles    Abstract available
     
     
     April 2006
182. RATLIFF TL
     Bladder cancer stage and outcome by array-based comparative genomic hybridization.
     J Urol. 2006;175:1568-9.
     PubMed     Related articles   
     
     
     
183. RATLIFF TL
     Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
     J Urol. 2006;175:1568.
     PubMed     Related articles   
     
     
     
184. MONTIE JE
     Bladder cancer outcome and subtype classification by gene expression.
     J Urol. 2006;175:1273.
     PubMed     Related articles   
     
     
     
185. AKKAD T , Gozzi C, Deibl M, Muller T, et al
     Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
     J Urol. 2006;175:1268-71.
     PubMed     Related articles    Abstract available
     
     
     
186. MESSING EM
     Bladder tumor markers.
     J Urol. 2006;175:1195-6.
     PubMed     Related articles   
     
     
     March 2006
187. AMSELLEM-OUAZANA D , Bieche I, Tozlu S, Botto H, et al
     Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.
     J Urol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
188. RIGAMONTI W , Iafrate M, Milani C, Capizzi A, et al
     Orthotopic continent urinary diversion after radical cystectomy in pediatric patients with genitourinary rhabdomyosarcoma.
     J Urol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
189. QUEK ML , Stein JP, Daneshmand S, Miranda G, et al
     A critical analysis of perioperative mortality from radical cystectomy.
     J Urol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
190. KAMAT AM , Gee JR, Dinney CP, Grossman HB, et al
     The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.
     J Urol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
191. HAUSER-KRONBERGER C , Peham K, Grall J, Rausch W, et al
     Novel approach of human epidermal growth factor receptor 2 detection in noninvasive and invasive transitional cell carcinoma of the bladder.
     J Urol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
192. KISHORE TA , George GK, Bhat S
     Virtual cystoscopy by intravesical instillation of dilute contrast medium: preliminary experience.
     J Urol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     December 2005
193. LEIBOVICI D , Kamat AM, Pettaway CA, Pagliaro L, et al
     CYSTOPROSTATECTOMY FOR EFFECTIVE PALLIATION OF SYMPTOMATIC BLADDER INVASION BY PROSTATE CANCER.
     J Urol 2005;174:2186-2190.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: